Pilot Study on a Health Promotion Intervention for Ultra-Orthodox Mothers of Children With ADHD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorAdina Maeir

About this trial

The goal of this study is to evaluate the feasibility and effectiveness of a health promotion intervention for Ultra-Orthodox Jewish mothers of children with ADHD.

This study will examine the impact of a culturally tailored group-based intervention aimed at reducing stress, enhancing health, and improving the well-being of mothers.

The main questions this study aims to answer are:

1. Is the intervention feasible for mothers to participate? 2. Does the intervention improve maternal knowledge about ADHD and reduce stigma? 3. Does it help reduce maternal stress and enhance self-care practices?

Participants include:

Mothers: Ultra-Orthodox Jewish mothers with a child (ages 6-12) diagnosed with ADHD and no other major health conditions in the family (other than ADHD).

Educators: School educators with at least 5 years of experience teaching children with ADHD in the Ultra-Orthodox community.

What participation involves:

Mothers will attend six weekly teletherapy group sessions, with 6-8 mothers per group. They will complete questionnaires before and after the intervention (approximately 30 minutes each) and participate in a 90-minute remote focus group to provide feedback on the program.

Educators will attend a single teletherapy group session (90 minutes) during the program (session 5) and participate in a 90-minute remote interview to provide feedback on the program.

Eligibility criteria

Qualifiers

mothers of children with ADHD aged 6- 12 years old

Mothers who identify as ultra-orthodox Jews

Child diagnosis was by a licensed medical professional

Disqualifiers

Child medical diagnosis other than ADHD

Trial design

Treatments tested in this trial

  • Health promotion for mothers of children with ADHD in the ultra-orthodox community

Treatment groups

32 Participants
are divided into 1 treatment group

Sponsors and collaborators

Adina Maeir

Lead sponsor

Hebrew University of Jerusalem

Sponsor institution

Monash University

Collaborator